Acetylator status and inhibition of platelet monoamine oxidase following treatment with pheneizine
- 1 May 1979
- journal article
- research article
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 9 (4) , 777-779
- https://doi.org/10.1017/s0033291700034127
Abstract
SYNOPSIS: The activity of platelet monoamine oxidase(MAO)was measured in 22 severely depressed patients before and after treatment with 45 mg and 60 mg phenelzine. The per cent inhibition of platelet MAO after both doses was not related to acetylator status.Phenelzine, since it is a hydrazine derivative, is probably metabolized by polymorphic acetylation. Patients who were phenotypically slow acetylators have been reported to show a better clinical response (Johnstone & Marsh, 1973) and more side-effects (Evanset al.1965) to a given dose of phenelzine than patients who were fast acetylators.Keywords
This publication has 6 references indexed in Scilit:
- A Multiple-Dose, Controlled Study of Phenelzine in Depression-Anxiety StatesArchives of General Psychiatry, 1976
- GANGLIOSIDES OF PERIPHERAL NERVE MYELINJournal of Neurochemistry, 1976
- The Monoamine Oxidase Inhibitor, Phenelzine, in the Treatment of Depressive-Anxiety StatesArchives of General Psychiatry, 1973
- New Look at Monoamine Oxidase InhibitorsProceedings of the Royal Society of Medicine, 1973
- Simplified Method for Determining Acetylator PhenotypeBMJ, 1972
- The influence of acetylator phenotype on the effects of treating depression with phenelzineClinical Pharmacology & Therapeutics, 1965